Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 18, 2013American Journal of Health-System Pharmacy

Implementation of pharmacist-managed anticoagulation in patients receiving newer anticoagulants

View Full Paper
Ask AI
Bookmark
Share

Population

Patients receiving newer anticoagulants (dabigatran, rivaroxaban, apixaban, edoxaban)

Design

Review

Authors

LCLinh L. ChanWCWalter L. CrumplerAJAlan K. Jacobson

Discussion

Loading...

Member takes

Overview

May inform pharmacist DOAC service expansion; leaves open need for outcome trials.

Structured PICO

P
Population
Patients receiving newer anticoagulants (dabigatran, rivaroxaban, apixaban, edoxaban)
I
Intervention
Pharmacist-managed anticoagulation

Discusses the potential role and implementation of pharmacist-managed anticoagulation services for patients receiving newer direct oral anticoagulants.

Cite This Study

Chan et al. (2013) studied this question.

synapsesocial.com/papers/6a815c63adfa6baaaee1cecahttps://doi.org/10.2146/ajhp120468
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1EVALUATION OF A PHARMACIST-MANAGED ANTICOAGULATION CLINIC1985 · 39 citations
  2. 2Outcome Analysis of a Pharmacist‐Managed Anticoagulation Service1995 · 163 citations
  3. 3Effect of Home Testing of International Normalized Ratio on Clinical Events2010 · 267 citations
  4. 4Cost-Justification of a Clinical Pharmacist-Managed Anticoagulation Clinic2007 · 80 citations
  5. 5Emergency Hospitalizations for Adverse Drug Events in Older Americans2011 · 1,845 citations